Christopher Ritchlin, MD, MPH

University of Rochester Medical Center
Canandaigua, NY, United States

Dr. Ritchlin is Professor in the Allergy, Immunology & Rheumatology Division at the University of Rochester Medical Center

Presentation(s):

• 1437: Bimekizumab Maintained Efficacy Responses Through 52 Weeks in Biologic Disease-Modifying Antirheumatic Drug-Naïve Patients with Psoriatic Arthritis Who Were Responders at Week 16: Results from a Phase 3, Active-Reference Study

  Monday, November 13, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): No relevant disclosure to display

• 2252: Bimekizumab Maintained Efficacy Responses Through 52 Weeks in Patients with Psoriatic Arthritis and Inadequate Response or Intolerance to TNF-α Inhibitors Who Were Responders at Week 16: Results from a Phase 3, Randomized Study

  Tuesday, November 14, 2023
  9:00 AM – 11:00 AM PT

  Disclosure(s): No relevant disclosure to display

• New Mouse Models in Psoriatic Arthritis

  Wednesday, November 15, 2023
  9:45 AM – 10:00 AM PT

  Disclosure(s): No relevant disclosure to display